WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of ALLERGAN INC (AGN)

Name ALLERGAN INC
Year low 69.40
Year High 97.09
Symbol AGN
Last trade 88.78
Percentage change -0.11
Volume 2,085,648
Media Volume (3m) 1,578,460
PE Ratio 27.42
EPS 3.241
Market Cap 26944
Media fatt 5530
Trend fatt trend fatt graph for ALLERGAN INC
Media net income 1034
Trend net income trend net income for ALLERGAN INC
P / E P / E graph for ALLERGAN INC - 9 points 9
EPS EPS graph for ALLERGAN INC - 15 points 15
MARKET CAP / TOTAL REVENUE market cap / total revenue graph for ALLERGAN INC - 0 points 0
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for ALLERGAN INC - 7 points 7
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for ALLERGAN INC - 9 points 9
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for ALLERGAN INC - 12 points 12
NET INCOME / MARKET CAP NET INCOME / MARKET CAP graph for ALLERGAN INC - 2 points 2
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for ALLERGAN INC - 4 points 4
NET INC1/NET INC3 net inc1/net inc3 graph for ALLERGAN INC - 7 points 7
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for ALLERGAN INC - 1 points 1
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for ALLERGAN INC - 4 points 4
. . graph for ALLERGAN INC - 0 points 0
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for ALLERGAN INC - 2 points 2
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for ALLERGAN INC - 0 points 0
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for ALLERGAN INC - 0 points 0
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for ALLERGAN INC - 3 points 3
. . graph for ALLERGAN INC - 0 points 0
SELL HOLD BUY SELL HOLD BUY graph for ALLERGAN INC - 0 points 0
SINTESE 75

GRAPHS

max price logarithm graph for ALLERGAN INC based on no conditions max volume linear graph for ALLERGAN INC based on no conditions

News

L'Oreal loses EU trademark battle to Allergan's Botox (May 10 - reuters) Wall Street Breakfast: Must-Know News (May 08 - reuters) Allergen receives subpoena over its anti-obesity device (May 08 - reuters) Allergan Management Discusses Q1 2012 Results - Earnings Call Transcript (May 02 - reuters) Botox maker Allergan cuts outlook, shares fall (May 02 - reuters) Allergan quarterly earnings rise (May 02 - reuters) Allergan Reports First Quarter 2012 Operating Results (May 02 - reuters) 3 Stocks I Saw on TV, May 2 (May 02 - reuters) Allergan: Earnings Preview (May 01 - reuters) A Very Compelling Biopharmaceutical Investment (Apr 18 - reuters) BOTOX®Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval (Apr 13 - reuters) Allergan Announces Quarterly Conference Call (Apr 06 - reuters) Bad Clinical Trial Trumps Good Acquisition (Apr 06 - reuters) Why Spectrum Pharmaceuticals Sank (Apr 05 - reuters) 4-Star Stocks Poised to Pop: Allergan (Apr 05 - reuters) Allergan Inc. - Special Call (Mar 29 - reuters) 3 Stocks to Get on Your Watchlist (Mar 28 - reuters) Allergan Botox works in overactive bladder studies (Mar 28 - reuters) Allergan Announces Positive Top-Line Results from Phase III BOTOX® Overactive Bladder Program (Mar 28 - reuters) Allergan Lap Band News Already Priced In (Mar 28 - reuters) TEXT-S&P summary: Allergan Inc. (Mar 23 - reuters) What Allergan Does With Its Cash (Mar 22 - reuters) VIX - Options Volatility Sonar: Thursday Recap (Mar 15 - reuters) Are Pharmaceuticals Set For A Run? (Mar 13 - reuters) TEXT-Fitch raises Allergan ratings (Mar 13 - reuters) U.S. Federal Court Finds in Favor of Allergan, Inc. and Issues Permanent Injunction against Merz Pharmaceuticals and Merz Aesthetics (Mar 12 - reuters) MAP Pharma: Making Money From Migraines (Mar 11 - reuters) Checking an Important Metric at Allergan (Mar 08 - reuters) UK cost agency unconvinced by Botox for migraine (Feb 17 - reuters) UPDATE 1-UK cost agency unconvinced by Botox for migraine (Feb 16 - reuters) Allergan Announces Research & Development Technology Review (Feb 15 - reuters) Fat-Burning Still Hot In Slow Economy, Says Solta CEO (Feb 10 - reuters) Valuation-Based Contrarian Picks (Feb 07 - reuters) Allergan to rely less on U.S. for sales, Asia key (Feb 03 - reuters) The Birth Control Pill Fiasco: Will It Be Bad For Pfizer? (Feb 03 - reuters) Allergan Management Discusses Q4 2011 Results - Earnings Call Transcript (Feb 02 - reuters) Allergan 4th-quarter profit, eye drug sales rise (Feb 02 - reuters) Allergan Reports Fourth Quarter 2011 Operating Results (Feb 02 - reuters) Patience With Palomar Could Pay (Jan 19 - reuters) Allergan sees Europe implant gains after scandal (Jan 11 - reuters) Allergan Announces Quarterly Conference Call (Jan 07 - reuters) MAP's Levadex: Blockbuster Potential With A March 26 PDUFA Date (Dec 15 - reuters) A look At Atlanta Sosnoff Capital's Top Buys (Nov 17 - reuters) Is Merck Working Hard Enough for You? (Nov 15 - reuters) Actress Christina Hendricks Urges Women to Join Her in the Final Weeks of the LATISSE® Wishes Challenge to Increase Money Raised for the Make-A-Wish Foundation® from $390,000 to Campaign Goal of $500,000 (Nov 09 - reuters) 5 High-Flying Stocks Investors Are Snapping Up (Nov 03 - reuters) Allergan Management Discusses Q3 2011 Results - Earnings Call Transcript (Oct 27 - reuters) Allergan Reports Third Quarter 2011 Operating Results (Oct 26 - reuters) 30 Days Later: 5 Jim Cramer Picks (Oct 23 - reuters) Allergan: High Quality, Pricey And Accounting Red Flags (Oct 13 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY